DiaMedica Therapeutics Inc (DMAC) — Cash Flow-to-Debt Ratio
DiaMedica Therapeutics Inc (DMAC) has a Cash Flow-to-Debt Ratio of -1.55x as of March 2026, meaning its operating cash flow of $-9.08 Million could theoretically repay -2% of its total liabilities ($5.84 Million) in one year. Explore DiaMedica Therapeutics Inc strategic investment ratio to see how much of total assets are deployed in long-term investments.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
DiaMedica Therapeutics Inc Cash Flow-to-Debt Ratio (2004–2025)
Historical debt coverage capacity for DiaMedica Therapeutics Inc across 22 annual periods. Also explore how large is DiaMedica Therapeutics Inc's balance sheet for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for DiaMedica Therapeutics Inc (2004–2025)
Year-by-year debt coverage analysis for DiaMedica Therapeutics Inc. For market capitalisation and broader financial context, see DiaMedica Therapeutics Inc (DMAC) total market value.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -5.53x | $-29.06 Million | $5.26 Million | ▼ -40.8% |
| 2024 | -3.92x | $-22.08 Million | $5.63 Million | ▲ +35.0% |
| 2023 | -6.04x | $-18.73 Million | $3.10 Million | ▼ -34.6% |
| 2022 | -4.48x | $-11.51 Million | $2.57 Million | ▲ +44.1% |
| 2021 | -8.02x | $-12.25 Million | $1.53 Million | ▼ -81.8% |
| 2020 | -4.41x | $-9.19 Million | $2.08 Million | ▲ +30.4% |
| 2019 | -6.34x | $-9.10 Million | $1.44 Million | ▼ -46.2% |
| 2018 | -4.33x | $-5.70 Million | $1.31 Million | ▼ -11.5% |
| 2017 | -3.89x | $-3.90 Million | $1.00 Million | ▲ +19.4% |
| 2016 | -4.82x | $-3.02 Million | $626.97K | ▼ -412.5% |
| 2015 | -0.94x | $-1.37 Million | $1.45 Million | ▲ +54.6% |
| 2014 | -2.07x | $-3.76 Million | $1.81 Million | ▲ +42.5% |
| 2013 | -3.61x | $-5.50 Million | $1.52 Million | ▼ -4.2% |
| 2012 | -3.47x | $-5.48 Million | $1.58 Million | ▲ +63.2% |
| 2011 | -9.42x | $-3.44 Million | $364.56K | ▼ -119.7% |
| 2010 | -4.29x | $-2.38 Million | $554.10K | ▲ +60.5% |
| 2009 | -10.85x | $-2.15 Million | $197.87K | ▼ -61.3% |
| 2008 | -6.73x | $-1.47 Million | $218.01K | ▼ -51.0% |
| 2007 | -4.45x | $-1.21 Million | $272.38K | ▲ +70.4% |
| 2006 | -15.04x | $-801.16K | $53.27K | ▼ -2.2% |
| 2005 | -14.71x | $-831.17K | $56.49K | ▼ -18803.4% |
| 2004 | -0.08x | $-99.35K | $1.28 Million | — |